
Phio Pharmaceuticals Corp. PHIO
$ 1.15
1.77%
Annual report 2025
added 03-05-2026
Phio Pharmaceuticals Corp. Shares 2011-2026 | PHIO
Annual Shares Phio Pharmaceuticals Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.98 M | 787 K | 232 K | 1.14 M | 1.07 M | 5.78 M | 460 K | 128 K | 41 K | 12.3 K | 9.04 K | 2.98 K | 1.87 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.98 M | 1.87 K | 1.2 M |
Quarterly Shares Phio Pharmaceuticals Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.47 M | 4.79 M | 4.31 M | 1.73 M | 990 K | 510 K | 4.58 M | 416 K | 271 K | 192 K | 1.14 M | 1.14 M | 1.14 M | 1.14 B | 1.13 M | 13.5 M | 13.5 M | 13.5 M | 10.7 M | 5.78 M | 5.78 M | 4.97 M | 1.77 M | 669 K | 462 K | 440 K | 371 K | 343 K | 4.37 M | 4.1 M | 2.49 M | 2.43 M | 2.35 M | 2.24 M | 2.06 M | 1.3 M | 658 K | 653 K | 653 K | 6.53 M | 6.49 M | 4.42 M | 2.38 M | 22 M | 17.5 M | 14 M | 12.6 M | 11.8 M | 11.6 M | 11.2 M | 6.5 M | 5.29 M | 5.24 M | 4.41 M | 48 B | 100 M | 42 M | 38.6 M | 100 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 48 B | 192 K | 842 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
220 M | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
4.28 M | - | - | $ 269 M | ||
|
BioNTech SE
BNTX
|
244 M | - | - | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
21.6 M | - | - | $ 231 M | ||
|
INmune Bio
INMB
|
24.8 M | $ 1.52 | -1.3 % | $ 37.6 M | ||
|
Exelixis
EXEL
|
272 M | $ 48.7 | 9.64 % | $ 13.2 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
166 M | $ 21.48 | -3.89 % | $ 3.56 B | ||
|
Fortress Biotech
FBIO
|
27.9 M | - | - | $ 71.1 M | ||
|
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
208 M | $ 3.15 | 1.19 % | $ 655 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
1.65 M | - | - | $ 5.51 M | ||
|
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
14.3 M | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
2.45 M | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
86.8 M | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
15.3 M | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
127 M | $ 24.17 | 3.2 % | $ 3.08 B | ||
|
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
25.4 M | - | 10.36 % | $ 9.8 M | ||
|
Applied Therapeutics
APLT
|
84.2 M | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
36.4 M | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
18.8 M | - | 17.91 % | $ 11.1 M | ||
|
CRISPR Therapeutics AG
CRSP
|
89.9 M | $ 55.08 | 5.15 % | $ 4.95 B | ||
|
Avenue Therapeutics
ATXI
|
3.13 M | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
266 M | $ 1.7 | 3.66 % | $ 452 M | ||
|
AVROBIO
AVRO
|
44.3 M | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | ||
|
Завод ДИОД
DIOD
|
91.5 M | - | - | - | ||
|
Фармсинтез
LIFE
|
301 M | - | - | - | ||
|
AstraZeneca PLC
AZN
|
1.42 B | - | - | $ 96.9 B | ||
|
Galapagos NV
GLPG
|
65.5 M | $ 28.81 | 1.48 % | $ 2.69 B | ||
|
Genmab A/S
GMAB
|
630 M | $ 27.89 | 1.34 % | $ 17.2 B |